InMed Pharmaceuticals Inc at OTC Markets Life Science Investor Forum (Virtual) Transcript

Mar 09, 2023 / 04:00PM GMT
Operator

Hello, and welcome to virtual investor conferences. My name is Celia, and on behalf of OTC Markets, we're very pleased you've joined us for our next live presentation from InMed Pharmaceuticals. (Conference Instruction) On a final note, all of today's presentations will be recorded and available for 24/7 replay.

At this point, I'm very pleased to welcome Eric Adams, President and CEO of InMed Pharmaceuticals, which trades on the Nasdaq under the symbol INM. Welcome, Eric.

Eric Adams - InMed Pharmaceuticals Inc. - CEO, President

Thank you. Glad to be here. I would like to give a short overview of the company and then afterwards, I will be accepting questions.

It's important as a NASDAQ traded company that everyone take a moment to look at the forward-looking statements. As a public company, it's important to review this and we will be using forward-looking statements in today's presentation.

So who is InMed? We are one of the few pure-play rare cannabinoid companies out there today. We have expertise across a wide range of scientific

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot